Prediction of Parkinson’s disease pathogenic variants using hybrid Machine learning systems and radiomic features

Gialluisi, 2021, Identification of sixteen novel candidate genes for late onset Parkinson’s disease, Mol Neurodegener, 16, 35, 10.1186/s13024-021-00455-2 Erb, 2020, LRRK2 and the endolysosomal system in Parkinson’s disease, J Parkinsons Dis, 4, 1271, 10.3233/JPD-202138 Bouhouche, 2017, LRRK2 G2019S mutation: prevalence and clinical features in Moroccans with Parkinson’s disease, Parkinsons Dis, 2017, 1, 10.1155/2017/2412486 Stoker, 2020, Recent developments in the treatment of Parkinson's Disease, F1000 Faculty Rev, 9, 862, 10.12688/f1000research.25634.1 Pakarulrazy, 2020, Glucocerebrosidase genetic variants in Malays with early and late-onset Parkinson's disease, Neurology Asia, 25, 39 Rieder, 2019, GBA mutations and Parkinson's disease in Brazil. SciELO, Brasil, 77, 71 Bandres-Ciga, 2020, Genetics of Parkinson's disease: an introspection of its journey towards precision medicine, Neurobiol Dis, 137, 10.1016/j.nbd.2020.104782 Jeong, 2020, Pathological functions of LRRK2 in Parkinson’s disease, Cells, 9, 2565, 10.3390/cells9122565 Nguyen, 2020, Dopaminergic neurodegeneration induced by Parkinson's disease-linked G2019S LRRK2 is dependent on kinase and GTPase activity, PNAS, 117, 17296, 10.1073/pnas.1922184117 Cookson, 2010, The role of leucine-rich repeat kinase 2 (LRRK2) in Parkinson's disease, Nat Rev Neurosci, 11, 791, 10.1038/nrn2935 Mills, 2012, Analysis of LRRK2 accessory repeat domains: prediction of repeat length, number and sites of Parkinson's disease mutations, Biochem Soc Trans, 40, 1086, 10.1042/BST20120088 Rui, 2018, The role of LRRK2 in neurodegeneration of Parkinson disease, Curr Neuropharmacol, 16, 1348, 10.2174/1570159X16666180222165418 Levy, 2020, The Parkinson's disease–associated kinase LRRK2 regulates genes required for cell adhesion, polarization, and chemotaxis in activated murine macrophages, J Biol Chem, 295, 10857, 10.1074/jbc.RA119.011842 Riboldi, 2019, GBA, Gaucher disease, and Parkinson’s disease: from genetic to clinic to new therapeutic approaches, Cells, 8, 364, 10.3390/cells8040364 Ortega, 2021, Association of dual lrrk2 g2019s and gba variations with parkinson disease progression, JAMA Netw Open, 4, e215845, 10.1001/jamanetworkopen.2021.5845 Blauwendraat, 2020, Genetic modifiers of risk and age at onset in GBA associated Parkinson’s disease and Lewy body dementia, Brain, 143, 234, 10.1093/brain/awz350 Barkhuizen, 2016, Advances in GBA-associated Parkinson's disease–Pathology, presentation and therapies, Neurochem Int, 93, 6, 10.1016/j.neuint.2015.12.004 Hajianfar, 2022, Hybrid Machine Learning Systems for Prediction of Parkinson’s Disease Pathogenic Variants Using Clinical Information and Radiomics Features, Journal of Nuclear Medicine, 63, 2508 Ferreira, 2017, An updated review of Parkinson's disease genetics and clinicopathological correlations, Acta Neurol Scand, 135, 273, 10.1111/ane.12616 Cook, 2021, Genetic testing for Parkinson disease: are we ready?, Neurol Clin Pract, 11, 69, 10.1212/CPJ.0000000000000831 Wallings, 2015, Cellular processes associated with LRRK 2 function and dysfunction, FEBS J, 282, 2806, 10.1111/febs.13305 Meireles, 2012, Cognitive impairment and dementia in Parkinson’s disease: clinical features, diagnosis, and management, Front Neurol, 3, 88, 10.3389/fneur.2012.00088 Massano, 2012, Clinical approach to Parkinson's disease: features, diagnosis, and principles of management, Cold Spring Harb Perspect Med, 2, a008870, 10.1101/cshperspect.a008870 Aerts, 2014, Decoding tumour phenotype by noninvasive imaging using a quantitative radiomics approach, Nat Commun, 5, 1 Lambin, 2017, Radiomics: the bridge between medical imaging and personalized medicine, Nat Rev Clin, 14, 749, 10.1038/nrclinonc.2017.141 Orlhac, 2021, Radiomics in PET imaging: a practical guide for newcomers, PET Clin, 16, 597, 10.1016/j.cpet.2021.06.007 Rutman, 2009, Radiogenomics: creating a link between molecular diagnostics and diagnostic imaging, Eur J Radiol, 70, 232, 10.1016/j.ejrad.2009.01.050 Hong, 2018, Radiogenomics correlation between MR imaging features and major genetic profiles in glioblastoma, Eur Radiol, 28, 4350, 10.1007/s00330-018-5400-8 Hajianfar, 2019, Noninvasive O6 methylguanine-DNA methyltransferase status prediction in glioblastoma multiforme cancer using magnetic resonance imaging radiomics features: univariate and multivariate radiogenomics analysis, World Neurosurg, 132, e140, 10.1016/j.wneu.2019.08.232 Shiri, 2020, Next-generation radiogenomics sequencing for prediction of EGFR and KRAS mutation status in NSCLC patients using multimodal imaging and machine learning algorithms, Mol Imag Biol, 22, 1132, 10.1007/s11307-020-01487-8 Mendoza, 2019, Computed tomography imaging characteristics of non–small-cell lung cancer with anaplastic lymphoma kinase rearrangements: a systematic review and meta-analysis, Clin Lung Cancer, 20, 339, 10.1016/j.cllc.2019.05.006 Arabi, 2021, The promise of artificial intelligence and deep learning in PET and SPECT imaging, Phys Med, 83, 122, 10.1016/j.ejmp.2021.03.008 Barragán-Montero, 2021, Artificial intelligence and machine learning for medical imaging: a technology review, Phys Med, 83, 242, 10.1016/j.ejmp.2021.04.016 Leung, 2018, Using deep-learning to predict outcome of patients with Parkinson’s disease, IEEE Nuclear Science Symposium and Medical Imaging Conference Proceedings (NSS/MIC), 1 Salmanpour, 2019, Optimized machine learning methods for prediction of cognitive outcome in Parkinson's disease, Computers in Biol Med, 111, 103347, 10.1016/j.compbiomed.2019.103347 Salmanpour, 2020, Machine learning methods for optimal prediction of motor outcome in Parkinson’s disease, Phys Med, 69, 233, 10.1016/j.ejmp.2019.12.022 Salmanpour, 2021, Feature selection and machine learning methods for optimal identification and prediction of subtypes in Parkinson’s disease, Comput Methods Programs Biomed, 206, 1, 10.1016/j.cmpb.2021.106131 Salmanpour, 2022, Longitudinal clustering analysis and prediction of Parkinson’s disease progression using radiomics and hybrid machine learning, Quant Imaging Med Surg, 12, 906, 10.21037/qims-21-425 Salmanpour, 2021, Robust identification of Parkinson’s disease subtypes using radiomics and hybrid machine learning, Computers in biology and medicine, 104142, 104142, 10.1016/j.compbiomed.2020.104142 Salmanpour, 2020, Hybrid machine learning methods for robust identification of Parkinson’s disease subtypes, Journal of Nuclear Medicine, 61 Salmanpour, 2020, Radiomic features combined with hybrid machine learning robustly identify Parkinson’s disease subtypes, Proc. Annual AAPM Meeting Salmanpour, 2020, Optimal feature selection and machine learning for prediction of outcome in Parkinson’s disease, J Nucl Med, 61 Salmanpour, 2022, Prediction of TNM stage in head and neck cancer using hybrid machine learning systems and radiomics features. In Medical Imaging 2022, Computer-Aided Diagnosis SPIE, 12033, 648 Salmanpour, 2021, Multitask outcome prediction using hybrid machine learning and PET-CT fusion radiomics, J Nucl Med, 61 Salmanpour, 2022, Deep versus handcrafted tensor radiomics features: Application to survival prediction in head and neck cancer, Eur J Nucl Med Mol Imaging, 49, S245 Salmanpour, 2022, Reliable and Reproducible Tensor Radiomics Features in Prediction of Survival in Head and Neck Cancer, Eur J Nucl Med Mol Imaging, 49 Hosseinzadeh, 2023, Prediction of Cognitive Decline in Parkinson’s Disease Using Clinical and DAT SPECT Imaging Features, and Hybrid Machine Learning Systems, Diagnostics, 13, 1691, 10.3390/diagnostics13101691 Salmanpour, 2023, Prediction of drug amount in Parkinson’s disease using hybrid machine learning systems and radiomics features, Int J Imaging Syst Technol, 33, 1437, 10.1002/ima.22868 Salmanpour, 2023, Application of novel hybrid machine learning systems and radiomics features for non-motor outcome prediction in Parkinson’s disease, Phys Med Biol, 68, 10.1088/1361-6560/acaba6 Fatan, 2021, Fusion-based head and neck tumor segmentation and survival prediction using robust deep learning techniques and advanced hybrid machine learning systems, 211 Initiative, 2011, The Parkinson Progression Marker Initiative (PPMI), Prog Neurobiol, 629–35 Benamer, 2000, Accurate differentiation of parkinsonism and essential tremor using visual assessment of [123I]-FP-CIT SPECT imaging: the [123I]-FP-CIT study group, Mov Disord, 15, 503, 10.1002/1531-8257(200005)15:3<503::AID-MDS1013>3.0.CO;2-V Catafau, 2004, Impact of dopamine transporter SPECT using 123I-Ioflupane on diagnosis and management of patients with clinically uncertain Parkinsonian syndromes, Mov Disord, 19, 1175, 10.1002/mds.20112 Varrone, 2013, European multicentre database of healthy controls for [123I]FP-CIT SPECT (ENC-DAT): age-related effects, gender differences and evaluation of different methods of analysis, Eur J Nucl Med Mol Imaging, 40, 213, 10.1007/s00259-012-2276-8 Zhu, 2010, An improved radiosynthesis of [18F]AV-133: a PET imaging agent for vesicular monoamine transporter 2, Nucl Med Biol, 37, 133, 10.1016/j.nucmedbio.2009.10.005 Siderowf, 2014, PET imaging of amyloid with Florbetapir F 18 and PET imaging of dopamine degeneration with 18F-AV-133 (florbenazine) in patients with Alzheimer's disease and Lewy body disorders, BMC Neurol, 14, 10.1186/1471-2377-14-79 Marek, 2018, The Parkinson's progression markers initiative (PPMI) - establishing a PD biomarker cohort, Ann Clin Transl Neurol, 5, 1460, 10.1002/acn3.644 Ashrafinia, 2019 Zwanenburg A, Leger S, Vallières M, Löck S. Image biomarker standardisation initiative. arXiv preprint arXiv: 161207003. 2016. Zwanenburg, 2020, The image biomarker standardization initiative: standardized quantitative radiomics for high-throughput image-based phenotyping, Radiol, 295, 328, 10.1148/radiol.2020191145 McNitt-Gray, 2020, Standardization in quantitative imaging: a multi-center comparison of radiomics features from different software packages on digital reference objects and patient datasets, Tomography, 6 Ben Sassi, 2012, Cognitive dysfunction in Tunisian LRRK2 associated Parkinson’s disease, Parkinsonism Relat Disord, 18, 243, 10.1016/j.parkreldis.2011.10.009 Nabli, 2015, Motor phenotype of LRRK2-associated Parkinson's disease: a tunisian longitudinal study, Mov Disord, 30, 253, 10.1002/mds.26097 Brockmann, 2015, GBA-associated Parkinson's disease: reduced survival and more rapid progression in a prospective longitudinal study, Mov Disord, 30, 407, 10.1002/mds.26071 Davis, 2016, Association of GBA mutations and the E326K polymorphism with motor and cognitive progression in Parkinson disease, JAMA Neurol, 73, 1217, 10.1001/jamaneurol.2016.2245 Shapiro, 1999, Construct and concurrent validity of the Hopkins Verbal Learning Test–revised, Clin Neuropsychol, 13, 348, 10.1076/clin.13.3.348.1749 Salmanpour, 2018, Machine learning methods for optimal prediction of outcome in Parkinson’s disease, IEEE Nuclear Science Symposium and Medical Imaging Conference Proceedings (NSS/MIC), 1 Salmanpour, 2023, Fusion-based tensor radiomics using reproducible features: Application to survival prediction in head and neck cancer, Computer Methods and Programs in Biomedicine, 240, 107714, 10.1016/j.cmpb.2023.107714 Salmanpour, 2023, Deep versus Handcrafted Tensor Radiomics Features: Prediction of Survival in Head and Neck Cancer Using Machine Learning and Fusion Techniques, Diagnostics, 13, 1696, 10.3390/diagnostics13101696 Simuni, 2020, Clinical and dopamine transporter imaging characteristics of non-manifest LRRK2 and GBA mutation carriers in the Parkinson's Progression Markers Initiative (PPMI): a cross-sectional study, Lancet Neurol, 19, 71, 10.1016/S1474-4422(19)30319-9 Prakash, 2012, Asymmetrical diffusion tensor imaging indices of the rostral substantia nigra in Parkinson's disease, Parkinsonism Relat Disord, 18, 1029, 10.1016/j.parkreldis.2012.05.021 Scherfler C, Seppi K, Mair KJ, Donnemiller E, Virgolini I, Wenning GK, et al. Left hemispheric predominance of nigrostriatal dysfunction in Parkinson's disease. Brain. 2012;135:3348-54. 10.1093/brain/aws253. Van Der Hoorn, 2012, Handedness correlates with the dominant Parkinson side: a systematic review and meta-analysis, Mov Disord, 27, 206, 10.1002/mds.24007 Barrett, 2011, Handedness and motor symptom asymmetry in Parkinson's disease, J Neurol Neurosurg Psychiatry, 82, 1122, 10.1136/jnnp.2010.209783 Claassen, 2016, Cortical asymmetry in Parkinson's disease: early susceptibility of the left hemisphere, Brain and Behavior: A Cognitive Neuroscience Perspective, 6, e00573, 10.1002/brb3.573 Brück, 2004, Hippocampal and prefrontal atrophy in patients with early non-demented Parkinson's disease is related to cognitive impairment, J Neurol Neurosurg Psychiatry, 75, 1467, 10.1136/jnnp.2003.031237 Mak, 2014, Cognitive deficits in mild Parkinson's disease are associated with distinct areas of grey matter atrophy, J Neurol Neurosurg Psychiatry, 85, 576, 10.1136/jnnp-2013-305805 Jubault, 2011, Patterns of cortical thickness and surface area in early Parkinson's disease, Neuroimage, 55, 462, 10.1016/j.neuroimage.2010.12.043 Su, 2021, Motor symptom lateralization influences cortico-striatal functional connectivity in Parkinson's disease, Front Neurol, 12, 10.3389/fneur.2021.619631 da Silva, 2017, Clinical profiles associated with LRRK2 and GBA mutations in Brazilians with Parkinson's disease, J Neurol Sci, 381, 160, 10.1016/j.jns.2017.08.3249